Skip to main content
. 2021 Apr 13;10:e65266. doi: 10.7554/eLife.65266

Table 1. Participant demographics.

Values given are median (lower quartile, upper quartile) or number (%). * Indicates missing data for one neonate.

Study 1 Study 3 Study 4
Control group Intervention group Control group Intervention group Template validation
Number of neonates 9 18 20 15 14 16
Gestational age (GA) at birth (weeks) 40.7 (40.3, 41) 40 (37.1, 40.7) 39.1 (37.1, 40.6) 27.6 (25.6, 28.8) 27.3 (26.3, 28.3) 40.6 (40, 41)
Postmenstrual age (PMA) at time of study (weeks) 41 (40.9, 41.7) 40.5 (37.6, 40.9) 39.5 (37.8, 41.1) 38 (37.2, 39.4) 37.2 (36.2, 38.1) 40.7 (40.1, 41.4)
Postnatal age (PNA) at time of study (days) 2 (2, 4) 1.5 (1, 3.5) 4 (2, 5) 64 (59, 90) 64 (62, 70.8) 2 (1, 3)
Birthweight (g) 4140 (3725, 4320) 3675 (3021, 3881) 3390 (3051, 3908) 1040 (705, 1268) 880 (708, 1031) 3520 (3103, 3786)
Sex
Male 4 (44) 11 (61) 9 (45) 9 (60) 9 (36) 12 (75)
Female 5 (56) 7 (39) 11 (55) 6 (40) 5 (64) 4 (25)
Mode of delivery
NVD (normal vaginal delivery) 2 (22) 6 (33) 7 (35) 6 (40) 3 (21.4) 8 (50)
Assisted vaginal ventouse/forceps 6 (67) 3 (17) 4 (20) 0 (0) 1 (7.1) 4 (25)
Emergency C-section 0 (0) 6 (33) 5 (25) 7 (47) 7 (50) 4 (25)
Elective C-section 1 (11) 3 (17) 4 (20) 2 (13) 3 (21.4) 0 (0)
Apgar score at 1 min 9 (8, 10) 9 (8, 10) 9 (7, 10) 5 (4, 6)* 7 (3, 8)* 9 (9, 10)
Apgar score at 5 min 10 (10, 10) 10 (10, 10) 10 (9, 10) 8 (7, 9)* 8 (7, 10)* 10 (10, 10)
Estimated cumulative prior pain exposure 4 (1, 4)* 2 (2, 6) 5 (3, 8)* 31 (28, 451) 78 (58, 219) 0 (0, 0)